Previous studies have reported that IFNA-expressing tumor cells enhance generation and promote survival of tumor-specific cytotoxic T lymphocytes [45] and that IFNA improves the anti-proliferative effect of EGFR inhibitors in CRC cell lines [27], [28]. The gene discussed is IFNA1; the disease is neoplasm.